Sakai Chemical Industry Co Ltd
TSE:4078
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/FCFF
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Valuation Scenarios
If EV/FCFF returns to its 3-Year Average (7.7), the stock would be worth ¥1 827.79 (51% downside from current price).
| Scenario | EV/FCFF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 15.7 | ¥3 710 |
0%
|
| 3-Year Average | 7.7 | ¥1 827.79 |
-51%
|
| 5-Year Average | 7.7 | ¥1 827.79 |
-51%
|
| Industry Average | 19.9 | ¥4 720.28 |
+27%
|
| Country Average | 20.9 | ¥4 939.47 |
+33%
|
Forward EV/FCFF
Today’s price vs future free cash flow to firm
Peer Comparison
| Market Cap | EV/FCFF | P/E | ||||
|---|---|---|---|---|---|---|
| JP |
S
|
Sakai Chemical Industry Co Ltd
TSE:4078
|
56.8B JPY | 15.7 | 13.6 | |
| ZA |
S
|
Sasol Ltd
JSE:SOL
|
145.7B ZAR | 13.7 | 60.5 | |
| DE |
|
Basf Se
XETRA:BAS
|
48.4B EUR | 47.7 | 29.9 | |
| CN |
|
Ningxia Baofeng Energy Group Co Ltd
SSE:600989
|
228.3B CNY | 19.8 | 17.9 | |
| JP |
|
Showa Denko KK
TSE:4004
|
2.6T JPY | 401.4 | 88.6 | |
| JP |
R
|
Resonac Holdings Corp
XMUN:SWD
|
13.8B EUR | 395.6 | 87.1 | |
| IN |
|
Pidilite Industries Ltd
NSE:PIDILITIND
|
1.4T INR | 67.4 | 60.6 | |
| ZA |
O
|
Omnia Holdings Ltd
JSE:OMN
|
14.6B ZAR | 4.9 | 12.3 | |
| JP |
M
|
Mitsubishi Chemical Group Corp
F:M3C0
|
7.1B EUR | 13.3 | 14.2 | |
| IN |
|
SRF Ltd
NSE:SRF
|
754B INR | 53.5 | 42.1 | |
| JP |
|
Mitsubishi Chemical Holdings Corp
TSE:4188
|
1.2T JPY | 12.9 | 13.6 |
Market Distribution
| Min | 0 |
| 30th Percentile | 13.6 |
| Median | 20.9 |
| 70th Percentile | 32.2 |
| Max | 571 930 627.1 |
Other Multiples
Sakai Chemical Industry Co Ltd
Glance View
Sakai Chemical Industry Co., Ltd. engages in provision of chemical products. The company is headquartered in Sakai-Shi, Osaka-Fu and currently employs 2,009 full-time employees. The firm operates in two business segments. Chemical segment is involved in the manufacture and sale of chemical products. Main products include titanium products, resin additives, barium products, catalyst products, electronic materials, zinc products, functional materials, and other chemicals such as organophosphorus compounds, organic sulfur compounds, as well as water treatment agents, among others. Medical segment is involved in the manufacture and sale of pharmaceuticals and quasi drugs. Main products include barium X-ray contrast media, medical drugs for peptic ulcer & reflux esophagitis, general drugs such as cold and gastrointestinal drugs, functional foods, as well as other products such as medical devices, among others.
